Search Within

Tiffany A Traina

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (49)
  2. Journal Article (34)
  3. Guidelines (1)
  4. Review (1)
Groups
  1. Biostatistics Service (85)
  2. Breast Medicine Service (85)
  3. Department of Medicine (85)
  4. Epidemiology and Biostatistics (85)
  5. Solid Tumor Oncology Division (85)
  6. Survivorship Research (85)

More Groups

People
  1. Sujata Patil (62)
  2. Clifford Hudis (47)
  3. Larry Norton (33)
  4. Ayca Gucalp (24)
  5. Chau Dang (20)
  6. Mark Robson (20)

More People

Years
  1. 2024 (5)
  2. 2023 (3)
  3. 2022 (5)
  4. 2021 (4)
  5. 2020 (4)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (25)
  2. Cancer Research (15)
  3. Breast Cancer Research and Treatment (7)
  4. Clinical Cancer Research (4)
  5. International Journal of Radiation Oncology, Biology, Physics (4)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (25)
  2. American Association for Cancer Research (19)
  3. Springer (13)
  4. Elsevier Inc. (10)
  5. Oxford University Press (4)
  6. John Wiley & Sons (3)

More Publishers

Results (85)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A feasibility study of bevacizumab plus dose-dense doxorubicin- cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer
    Journal Article

    Mcarthur, H. L.; Rugo, H.; Nulsen, B.; Hawks, L.; Grothusen, J.; Melisko, M.; Moasser, M.; Paulson, M.; Traina, T.; Patil, S.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Phase II trial of saracatinib in patients (pts) with ER/PR-negative metastatic breast cancer (MBC)
    Meeting Abstract

    Traina, T. A.; Sparano, J. A.; Caravelli, J.; Patil, S.; Abbruzzi, A.; Hawke, R.; Bromberg, J.; Nonemaker, J.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A novel capecitabine schedule (7 on—7 off) is feasible with lapatinib for patients with HER2-positive metastatic breast cancer refractory to trastuzumab
    Meeting Abstract

    Gajria, D.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Drullinsky, P.; D'Andrea, G.; Lake, D.; Norton, L.; Hudis, C.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer
    Journal Article

    Traina, T. A.; Rugo, H. S.; Caravelli, J. F.; Patil, S.; Yeh, B.; Melisko, M. E.; Park, J. W.; Geneus, S.; Paulson, M.; Grothusen, J.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer
    Journal Article

    Pugliese, M. S.; Karam, A. K.; Hsu, M.; Stempel, M. M.; Patil, S. M.; Ho, A. Y.; Traina, T. A.; Van Zee, K. J.; Cody, H. S. 3rd; Morrow, M.; more...
    Annals of Surgical Oncology (2010)

    Fulltext@MSK | Save
  • The clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancer
    Journal Article

    Pugliese, M.; Stempel, M.; Patil, S.; Hsu, M.; Ho, A.; Traina, T.; Morrow, M.; Cody, H. S. 3rd; Gemignani, M. L.
    American Journal of Surgery (2010)

    Fulltext@MSK | Save
  • Dose dense cyclophosphamide, methotrexate, fluorouracil is feasible at 14-day intervals: a pilot study of every-14-day dosing as adjuvant therapy for breast cancer
    Journal Article

    Drullinsky, P.; Sugarman, S. M.; Fornier, M. N.; D'Andrea, G.; Gilewski, T.; Lake, D.; Traina, T.; Wasserheit-Lieblich, C.; Sklarin, N.; Atieh-Graham, D.; more...
    Clinical Breast Cancer (2010)

    Fulltext@MSK | Save
  • Safety of a novel capecitabine dosing schedule when combined with lapatinib in patients with HER2-positive metastatic breast cancer refractory to trastuzumab
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Modi, S.; Fornier, M.; Lake, D.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Determinants of outcome in elderly patients with positive sentinel lymph nodes
    Meeting Abstract

    Gemignani, M.; Karam, A.; Hsu, M.; Patil, S.; Stempel, M.; Traina, T.; Ho, A.; Cody, H. 3rd; Morrow, M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Patil, S.; Geneus, S.; Godfrey, L.; Norton, L.; Hudis, C.
    Cancer Research (2009)

    Fulltext@MSK | Save